Anthropic launched Claude Science in beta today, calling it an “AI workbench for scientists.” The tool pulls fragmented tools and datasets into one environment, and generates figures and visuals like 3D protein structures. Anthropic stresses “Claude Science is not a new AI model” — a noteworthy caveat amid ongoing drama surrounding its last rollout. [Image: Claude Science is starting with biology in beta, but Anthropic has plans to expand beyond that. https://platform.theverge.com/wp-content/uploads/sites/2/2026/06/Claude-Science-Product-Image_01_Embargoed-Until-Tuesday-June-30-2026-10am-PT.png?quality=90&strip=all]

Anthropic's Claude Science is a capable AI research workbench built for molecular biology. The opportunities for the rest of science are enormous.

Anthropic's Claude Science is an AI workbench that unifies a scientist's tools and lets agents run the analysis, with a reviewer agent to check it.

The launch is part of Anthropic's life sciences and healthcare initiative, which the IPO-bound company has been developing since October 2025.

The company is doubling down on AI for science.